Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Seeking Alpha, 13 Oct 2023 Summary Phase 3 trial failures were due to abnormally high placebo responses driven by poor trial design, enrollment, and…